Obesity and endometrial cancer survival: A systematic review

International Journal of Obesity

Volumn 37, Issue 5, 2013, Pages 634-639

  Arem, H ^a   Irwin, M L ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

body mass index; endometrial neoplasms; mortality; survivorship

Indexed keywords

BODY MASS; CANCER MORTALITY; CANCER SURVIVAL; CANCER SURVIVOR; CORRELATIONAL STUDY; ENDOMETRIUM CANCER; FEMALE; HUMAN; MEDLINE; OBESITY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROSPECTIVE STUDY; REVIEW; SURVIVAL; SYSTEMATIC REVIEW;

ADULT; AGE OF ONSET; BODY MASS INDEX; DISEASE-FREE SURVIVAL; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; MIDDLE AGED; OBESITY; RISK FACTORS; SEDENTARY LIFESTYLE; SURVIVAL ANALYSIS; UNITED STATES; WOMEN'S HEALTH;

EID: 84877577954     PISSN: 03070565     EISSN: 14765497     Source Type: Journal    
DOI: 10.1038/ijo.2012.94     Document Type: Review

References (39)

1. National Cancer Institute. Endometrial Cancer. In: What You Need to Know About Cancer of the Uterus. National Cancer Institute: Bethesda, 2012.
2. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011. CA Cancer J Clin 2011; 61: 212-236.
3. Terry P, Baron JA, Weiderpass E, Yuen J, Lichtenstein P, Nyren O. Lifestyle and endometrial cancer risk: a cohort study from the Swedish twin registry. Int J Cancer 1999; 82: 38-42.
4. Spurdle AB, Thompson DJ, Ahmed S, Ferguson K, Healey CS, O'Mara T et al. Genome-wide association study identifies a common variant associated with risk of endometrial cancer. Nat Genet 2011; 43: 451-454.
5. Amant F, Moerman P, Neven P, Timmerman D, Van Limbergen E, Vergote I. Endometrial cancer. Lancet 2005; 366: 491-505.
6. Obermair A, Manolitsas TP, Leung Y, Hammond IG, McCartney AJ. Total laparoscopic hysterectomy for endometrial cancer: patterns of recurrence and survival. Gynecol Oncol 2004; 92: 789-793.
7. Jemal A, Siegel R, Xu J, Ward E. Cancer Statistics, 2010. CA Cancer J Clin 2010; 60: 277-300.
8. Fader AN, Arriba LN, Frasure HE, von Gruenigen VE. Endometrial cancer and obesity: epidemiology, biomarkers, prevention and survivorship. Gynecol Oncol 2009; 114: 121-127.
9. Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003; 348: 1625-1638.
10. Reeves GK, Pirie K, Beral V, Green J, Spencer E, Bull D. Cancer incidence and mortality in relation to body mass index in the Million Women Study: cohort study. BMJ 2007; 335: 1134.
11. Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath Jr CW. Body-mass index and mortality in a prospective cohort of U.S. adults. N Engl J Med 1999; 341: 1097-1105.
12. Adams KF, Schatzkin A, Harris TB, Kipnis V, Mouw T, Ballard-Barbash R et al. Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old. N Engl J Med 2006; 355: 763-778.
13. McTiernan A, Irwin M, Vongruenigen V. Weight, physical activity, diet, and prognosis in breast and gynecologic cancers. J Clin Oncol 2010; 28: 4074-4080.
14. Basen-Engquist K, Scruggs S, Jhingran A, Bodurka DC, Lu K, Ramondetta L et al. Physical activity and obesity in endometrial cancer survivors: associations with pain, fatigue, and physical functioning. Am J Obstet Gynecol 2009; 200: 288.e1-288.e8.
15. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Open Medicine: A Peer-Reviewed, Independent, Open-Access Journal 2009; 3: e123-e130.
16. Chia VM, Newcomb PA, Trentham-Dietz A, Hampton JM. Obesity, diabetes, and other factors in relation to survival after endometrial cancer diagnosis. Int J Gynecol Cancer 2007; 17: 441-446.
17. Modesitt SC, Tian C, Kryscio R, Thigpen JT, Randall ME, Gallion HH et al. Impact of body mass index on treatment outcomes in endometrial cancer patients receiving doxorubicin and cisplatin: a Gynecologic Oncology Group study. Gynecol Oncol 2007; 105: 59-65.
18. Mauland KK, Trovik J, Wik E, Raeder MB, Njolstad TS, Stefansson IM et al. High BMI is significantly associated with positive progesterone receptor status and clinico-pathological markers for non-aggressive disease in endometrial cancer. Br J Cancer 2011; 104: 921-926.
19. von Gruenigen VE, Tian C, Frasure H, Waggoner S, Keys H, Barakat RR. Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma. Cancer 2006; 107: 2786-2791.
20. Gates EJ, Hirschfield L, Matthews RP, Yap OWS. Body mass index as a prognostic factor in endometrioid adenocarcinoma of the endometrium. J Natl Med Assoc 2006; 98: 1814.
21. Anderson B, Connor JP, Andrews JI, Davis CS, Buller RE, Sorosky JI et al. Obesity and prognosis in endometrial cancer. Am J Obstet Gynecol 1996; 174: 1171-1178; discussion 1178-1179.
22. Everett E, Tamimi H, Greer B, Swisher E, Paley P, Mandel L et al. The effect of body mass index on clinical/pathologic features, surgical morbidity, and outcome in patients with endometrial cancer. Gynecol Oncol 2003; 90: 150-157.
23. Jeong NH, Lee JM, Lee JK, Kim JW, Cho CH, Kim SM et al. Role of body mass index as a risk and prognostic factor of endometrioid uterine cancer in Korean women. Gynecol Oncol 2010; 118: 24-28.
24. Kodama J, Seki N, Ojima Y, Nakamura K, Hongo A, Hiramatsu Y. Correlation of presenting symptoms and patient characteristics with endometrial cancer prognosis in Japanese women. Int J Gynaecol Obstet 2005; 91: 151-156.
25. Temkin SM, Pezzullo JC, Hellmann M, Lee YC, Abulafia O. Is body mass index an independent risk factor of survival among patients with endometrial cancer? Am J Clin Oncol 2007; 30: 8-14.
26. Munstedt K, Wagner M, Kullmer U, Hackethal A, Franke FE. Influence of body mass index on prognosis in gynecological malignancies. Cancer Causes Control 2008; 19: 909-916.
27. Studzinski Z, Zajewski W. Factors affecting the survival of 121 patients treated for endometrial carcinoma at a Polish hospital. Arch Gynecol Obstet 2003; 267: 145-147.
28. von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 2007; 370: 1453-1457.
29. Foley K, Lee RB. Surgical complications of obese patients with endometrial carcinoma. Gynecol Oncol 1990; 39: 171-174.
30. Villareal DT, Apovian CM, Kushner RF, Klein S. Obesity in older adults: technical review and position statement of the American Society for Nutrition and NAASO, the obesity society. Am J Clin Nutr 2005; 82: 923-934.
31. Calle EE, Kaaks R. Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms. Nat Rev Cancer 2004; 4: 579-591.
32. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous hormones, and endometrial cancer risk: a synthetic review. Cancer Epidemiol Biomarkers Prev 2002; 11: 1531-1543.
33. Akhmedkhanov A, Zeleniuch-Jacquotte A, Toniolo P. Role of exogenous and endogenous hormones in endometrial cancer. Ann NY Acad Sci 2001; 943: 296-315.
34. Blanchard CM, Courneya KS, Stein K. Cancer survivors' adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society's SCS-II. J Clin Oncol 2008; 26: 2198-2204.
35. Courneya KS, Karvinen KH, Campbell KL, Pearcey RG, Dundas G, Capstick V et al. Associations among exercise, body weight, and quality of life in a population-based sample of endometrial cancer survivors. Gynecol Oncol 2005; 97: 422-430.
36. Lynch BM. Sedentary behavior and cancer: a systematic review of the literature and proposed biological mechanisms. Cancer Epidemiol Biomarkers Prev 2010; 19: 2691-2709.
37. Moore SC, Gierach GL, Schatzkin A, Matthews CE. Physical activity, sedentary behaviours, and the prevention of endometrial cancer. Br J Cancer 2010; 103: 933-938.
38. von Gruenigen VE, Courneya KS, Gibbons HE, Kavanagh MB, Waggoner SE, Lerner E. Feasibility and effectiveness of a lifestyle intervention program in obese endometrial cancer patients: a randomized trial. Gynecol Oncol 2008; 109: 19-26.
39. Sorosky JI. Endometrial cancer. Obstet Gynecol 2008; 111(2 Pt 1): 436-447.